As one of the selected leading solution providers at this year's LogiPharma 4.0 Connect, we look forward to meeting many of our customers and taking part in conversations that will contribute to shaping the future course of pharma supply chain digital transformation.
From improving transparency by leveraging IoT, to optimizing the value of data-driven insight, the themes at LogiPharma Connect this year strongly resonate with Controlant’s solutions and strategy.
In addition to the panel discussions, meetings, and roundtables at this unique event, we especially look forward to joining Teva Pharmaceuticals' Val Pétursson (Senior Director, Head of Global Logistics) on stage for a keynote presentation with Ada Pálmadóttir, VP Business Development at Controlant - see details below.
We look forward to two intense days of brainstorming, benchmarking, and pushing the bounds of digital supply chain innovation.
The control-tower approach is about connecting dashboards and aggregating relevant data to inform strategic decisions that increase supply chain efficiency. Control towers built on real-time visibility enable a much greater level of actionability.
In this keynote address, Val and Ada explore the value of proactive interventions through real-time alerts, which is key to how pharma companies are leveraging IoT to improve transparency across supply chain networks. They share insights from a current pilot of Controlant’s 24/7 hypercare solution for highly sensitive medicines, and look at current data-harnessing developments in heat-mapping and mitigations, as well as product stability automation.
Senior Director, Head of Global Logistics, TEVA Pharmaceuticals
Val is a supply chain professional with 20+ years’ experience in executive roles within pharma logistics and healthcare supply chain. He has worked within pharmalogistics for the past 12 years; first with Actavis/Allergan, before joining Teva Pharmaceuticals in 2016. Teva is the world’s largest generic pharma company, serving 200 million patients every day, through a large, complex global network of own sites, CMOs, and patients. Val is a pioneer in 4PL (LLP) concepts for pharma and has held advisory roles for various pharma service providers since 2012.